Banking & Finance  April 2, 2021

Funding Friday: Two Boulder biotechs going public

Welcome to Funding Friday, BizWest’s roundup of companies in Northern Colorado and the Boulder Valley kicking off fundraisers.

BizWest reports fundraisers by companies in Boulder, Broomfield, Larimer and Weld counties, as well as Brighton and Westminster through regulatory filings, press releases and other sources. Did we miss a company’s round? Email us at news@bizwest.com.

Notable rounds this week:

  • Protein-analysis developer SomaLogic Inc. announced plans to go public via a SPAC merger in the third quarter of this year in a move that will add $686 million in cash to its balance sheet. The deal values SomaLogic as a unicorn at $1.23 billion before the go-public deal is consummated.
  • Edgewise Therapeutics Inc. (Nasdaq: EWTX) raised $202.4 million from its surprise initial public offering this week after confidentially filing to go public in early March. The Boulder biopharmaceutical producer did not say exactly how much it’ll keep from the sale after paying underwriter’s fees.

Other rounds (Source: SEC)

SPONSORED CONTENT

March 31: SmartDeFi Inc., Fort Collins, $660,000 raised in ongoing round.

© 2021 BizWest Media LLC

Welcome to Funding Friday, BizWest’s roundup of companies in Northern Colorado and the Boulder Valley kicking off fundraisers.

BizWest reports fundraisers by companies in Boulder, Broomfield, Larimer and Weld counties, as well as Brighton and Westminster through regulatory filings, press releases and other sources. Did we miss a company’s round? Email us at news@bizwest.com.

Notable rounds this week:

  • Protein-analysis developer SomaLogic Inc. announced plans to go public via a SPAC merger in the third quarter of this year in a move that will add $686 million in cash to its balance sheet. The deal values SomaLogic as a unicorn at $1.23 billion…

Related Posts

Sign up for BizWest Daily Alerts